GSK-SLMF4010

Study Sponsor: GSK

Study Title

Multicentre, randomised, parallel group, placebo-controlled, double-blind, study, stratified on tobacco status at enrollment, evaluating during 6 months the efficacy of salmeterol powder for inhalation, 50 µg two times per day for the reduction of thoracic distension in subjects with chronic ob ...

Medicine or Vaccine (generic name)

salmeterol

Sponsor Identification Number

SLMF4010

Trial Registry Identification Number(#'s)

N/A

Medical Condition

Pulmonary Disease, Chronic Obstructive

Phase

Phase 4

Link to GSK Study Register

http://www.gsk-clinicalstudyregister.com/study/SLMF4010

Link to study details on ClinicalTrials.gov (if available)

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

All or some of the data and documents for this study are in a non-English language and anonymisation may take longer. An annotated case report form is not available for this study. A blank case report form will be provided. A link to Clinicaltrials.gov and a NCT ID number are not available for this study because the study was conducted before regulatory requirements to register studies.

Date Added to this Site

September 2013